Nine Dean, a newly established holding company, announced its official launch. Backed by a significant anchor investment from the Ford Foundation and founded...
Blackstone Life Sciences and Anthos Therapeutics, Inc., a transformative, clinical-stage biopharmaceutical company developing innovative therapies for the treatment of cardiometabolic diseases, announced that Novartis...
Blackstone Life Sciences and Anthos Therapeutics, Inc. (Anthos or the company), a transformative, clinical-stage biopharmaceutical company developing innovative therapies for the treatment of...
